A Promising Candidate for a Lassa Fever Vaccine.

A Promising Candidate for a Lassa Fever Vaccine.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2005-06-01
Series:	PLoS Medicine
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1160596/?tool=EBI

Similar Items

Advanced Vaccine Candidates for Lassa Fever
by: Igor S. Lukashevich
Published: (2012-10-01)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
by: Cashman Kathleen A, et al.
Published: (2010-10-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01)

Development of a new vaccine for the prevention of Lassa fever.
by: Thomas W Geisbert, et al.
Published: (2005-06-01)

Development of a new vaccine for the prevention of Lassa fever.
Published: (2005-06-01)

Pathogenesis of Lassa Fever
by: David H. Walker, et al.
Published: (2012-10-01)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
by: Tiago Abreu-Mota, et al.
Published: (2018-10-01)

Current research for a vaccine against Lassa hemorrhagic fever virus
by: Warner BM, et al.
Published: (2018-08-01)

Lassa viral hemorrhagic fever
by: Viroj Wiwanitkit
Published: (2020-01-01)

Animal Models of Lassa Fever
by: Rachel A. Sattler, et al.
Published: (2020-03-01)

Lassa Fever Viral Replication, Disease Pathogenesis, and Host Immune Modulations
Published: (2020)

Imported Lassa Fever in Germany:  Molecular Characterization of a New Lassa Virus Strain
by: Stephan Günther, et al.
Published: (2000-10-01)

Modeling the dynamics of Lassa fever in Nigeria
by: Mayowa M. Ojo, et al.
Published: (2021-07-01)

T cell-dependence of Lassa fever pathogenesis.
by: Lukas Flatz, et al.
Published: (2010-03-01)

Laboratory Diagnosis of Lassa Fever, Liberia
by: Marcus Panning, et al.
Published: (2010-06-01)

Pathogenesis of lassa fever in cynomolgus macaques
by: Fritz Elizabeth A, et al.
Published: (2011-05-01)

Ribavirin for Lassa Fever Postexposure Prophylaxis
by: Christiane M. Hadi, et al.
Published: (2010-12-01)

Lassa Fever, Nigeria, 2003 and 2004
by: Sunday Aremu Omilabu, et al.
Published: (2005-10-01)

Lassa Fever, Nigeria, 2005–2008
by: Deborah U. Ehichioya, et al.
Published: (2010-06-01)

Contact Tracing and Profile of Lassa Fever Contacts in Edo State, Nigeria: Implications for the Control of Lassa Fever Outbreaks
by: Faith Ireye, et al.
Published: (2021-01-01)

Lassa fever and the Nigerian experience: a review
by: Samuel Ebiojo Amodu, et al.
Published: (2019-07-01)

A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
by: Yingyun Cai, et al.
Published: (2020-03-01)

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
by: Yingyun Cai, et al.
Published: (2020-02-01)

Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1-/- Mice
by: Dylan M. Johnson, et al.
Published: (2019-01-01)

Time to reconsider the role of ribavirin in Lassa fever.
by: Alex Paddy Salam, et al.
Published: (2021-07-01)

Lassa fever in post-conflict sierra leone.
by: Jeffrey G Shaffer, et al.
Published: (2014-03-01)

Molecular confirmation of Lassa fever imported into Ghana
by: Joseph H.K. Bonney, et al.
Published: (2016-04-01)

Mastomys natalensis and Lassa Fever, West Africa
by: Emilie Lecompte, et al.
Published: (2006-12-01)

Risk maps of Lassa fever in West Africa.
by: Elisabeth Fichet-Calvet, et al.
Published: (2009-01-01)

Imported Lassa Fever, Pennsylvania, USA, 2010
by: Valerianna Amorosa, et al.
Published: (2010-10-01)

Dealing with the unseen: Ffear and stigma in lassa fever
by: D. Asogun, et al.
Published: (2014-04-01)

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
by: David Safronetz, et al.
Published: (2015-04-01)

Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.
by: Juan Carlos Zapata, et al.
Published: (2013-01-01)

Lassa fever-induced hearing loss: The neglected disability of hemorrhagic fever
by: Samuel C. Ficenec, et al.
Published: (2020-11-01)

Lassa fever: History, causes, effects, and reduction strategies
by: Promise Tewogbola, et al.
Published: (2020-08-01)

Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
by: Lucy E. Horton, et al.
Published: (2020-11-01)

Modelling and optimal control analysis of Lassa fever disease
by: Olumuyiwa James Peter, et al.
Published: (2020-01-01)

Mathematical Modelling and Analysis of Transmission Dynamics of Lassa Fever
by: E. A. Bakare, et al.
Published: (2020-01-01)

Lassa and Crimean-Congo Hemorrhagic Fever Viruses, Mali
by: Jan Baumann, et al.
Published: (2019-05-01)

Lassa fever in West African sub-region: an overview
by: O. Ogbu, et al.
Published: (2007-01-01)